Prevalence and awareness of Herpes Zoster Among Saudi Patients with Diabetes Mellitus, A Cross Sectional Study in Al-Ahsa, Saudi Arabia
Abstract
Background: Herpes zoster (HZ) is a painful vesicular rash that happens when an infection with the varicella-zoster virus in the sensory ganglia is reactivated. The incidence and severity of HZ and its complications increase with advancing age, with a marked increase after 50 years of age. In addition, diabetes mellitus has been found to be a risk factor for severe, persistent postherpetic neuralgia.
Methods: This descriptive cross-sectional hospital-based study was conducted in Al-Ahsa City, Eastern Saudi Arabia, in 2023. The study population included patients with DM who visit outpatient (ambulatory care) in primary or secondary health care setting. The convenience sample included 224 participants. A validated closed-ended interview questionnaire was used to collect data. The collected data were analyzed by the SPSS program version 28, and both descriptive and inferential statistics were used.
Results: The study included 224 participants, more than half (54.5%) of whom were female. The mean (SD) age of the sample was 61.1 ± 8 years. Most of the participants (97.8%) were married, and 29.0% had a secondary school education level. More than half of the participants (56.7%) had heard of HZ. Only 6.7% had been diagnosed with HZ, and 23.7% knew someone who had been diagnosed with HZ. In addition, 18.8% had been vaccinated against HZ. Most patients (80.8%) cited healthcare providers as their primary source of HZ knowledge, followed by friends/relatives (37.9%). More than half of the participants were aware of HZ (62.1%) and had a positive attitude towards HZ (55.8%) respectively. Awareness of HZ was positively correlated with a higher level of education, a high income, a short duration of diabetes, having heard of HZ, being diagnosed with HZ, knowing someone who had been diagnosed with HZ, and being vaccinated against HZ among diabetic patients.
Conclusion: The results revealed low vaccination rates and low awareness of HZ. The study recommends that education in simple language should be provided through various media to increase community awareness about HZ and its vaccine. Additionally, healthcare providers should promote and recommend HZ vaccinations for DM patients.
Keywords:
DM, Herpes zoster, Varicella zoster, Vaccine, Awareness, Attitude, Saudi ArabiaDOI
https://doi.org/10.37022/wjcmpr.v5i4.278References
Oxman MN: Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. J Osteopath Med. 2009, 109:13–7. 10.7556/jaoa.2009.20009
Gilden D, Mahalingam R, Nagel M, Pugazhenthi S, Cohrs R: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol. 2011, 37:441–63. 10.1111/j.1365-2990.2011.01167.x.
Opstelten W, van Loon AM, Schuller M, van Wijck AJ, van Essen GA, Moons KG, Verheij TJ: Clinical diagnosis of herpes zoster in family practice. Ann Fam Med. 2007, 5:305–9. 10.1370/afm.707
Yawn BP, Saddier P, Wollan PC, Sauver JLS, Kurland MJ, Sy LS: A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Elsevier; 2007. 1341–9.10.4065/82.11.1341
Diabetes in Saudi Arabia (2021). (2021). https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/saudi-arabia/.
Papagianni M, Metallidis S, Tziomalos K: Herpes zoster and diabetes mellitus: a review. Diabetes Ther. 2018, 9:545–50. 10.1007/s13300-018-0394-4
Anderson TC, Masters NB, Guo A, et al.: Use of recombinant zoster vaccine in immunocompromised adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. Am J Transplant. 2022, 22:986–90. 10.15585/mmwr.mm7103a2
Harbecke R, Cohen JI, Oxman MN: Herpes zoster vaccines. J Infect Dis. 2021, 224:S429–42.
Munoz-Quiles C, López-Lacort M, Ampudia-Blasco FJ, Díez-Domingo J: Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009–2014. Hum Vaccines Immunother. 2017, 13:2606–11. 10.1080/21645515.2017.1368600
Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V: Type 2 diabetes: demystifying the global epidemic. Diabetes. 2017, 66:1432–42. 10.2337/db16-0766
Galanos G, Dimitriou H, Pappas A, Perdikogianni C, Symvoulakis EK, Galanakis E, Lionis C: Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece. Front Public Health. 2022, 10:. 10.3389/fpubh.2022.921243
Abdulaziz Al Dawish M, Alwin Robert A, Braham R, Abdallah Al Hayek A, Al Saeed A, Ahmed Ahmed R, Sulaiman Al Sabaan F: Diabetes mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. 2016, 12:359–68. 10.2174/1573399811666150724095130
Chen L-K, Arai H, Chen L-Y, et al.: Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis. 2017, 17:1–39. 10.1186/s12879-017-2198-y
Roh NK, Park YM, Kang H, et al.: Awareness, knowledge, and vaccine acceptability of herpes zoster in Korea: a multicenter survey of 607 patients. Ann Dermatol. 2015, 27:531–8. 10.5021/ad.2015.27.5.531
Yawn BP, Merrill DD, Martinez S, Callen E, Cotton J, Williams D, Loskutova NY: Knowledge and attitudes concerning herpes zoster among people with COPD: an interventional survey study. Vaccines. 2022, 10:420. 10.3390/vaccines10030420
Tricco AC, Zarin W, Cardoso R, et al.: Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. bmj. 2018, 363:. 10.1136/bmj.k4029
Alhothali OS, Alhothali AS, Hanif AA, et al.: A Cross-Sectional Study of the Knowledge, Practice, and Attitude Towards Herpes Zoster Vaccination Among the General Population in the Western Region of Saudi Arabia. Cureus. 2023, 15:. 10.7759/cureus.33508
Al-Orini D, Alshoshan AA, Almutiri AO, et al.: Acceptability of Herpes Zoster Vaccination among Patients with Diabetes: A Cross-Sectional Study in Saudi Arabia. Vaccines. 2023, 11:651. 10.3390/vaccines11030651
Al-Khalidi T, Genidy R, Almutawa M, et al.: Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: a cross-sectional study. Hum Vaccines Immunother. 2022, 18:2073752. 10.1080/21645515.2022.2073752
Baalbaki NA, Fava JP, Ng M, et al.: A community-based survey to assess knowledge, attitudes, beliefs and practices regarding Herpes Zoster in an urban setting. Infect Dis Ther. 2019, 8:687–94. 10.1007/s40121-019-00269-2
Wang Q, Yang L, Li L, Liu C, Jin H, Lin L: Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis. JMIR Public Health Surveill. 2023, 9:e43893. 10.2196/43893
Lam AC, Chan M, Chou H, et al.: A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J. 2017, 23:365. 10.12809/hkmj165043
Tomas N, Kampanza F: Awareness of varicella-zoster virus among undergraduate students at the University of Namibia. J Public Health Afr. 2022, 13:. 10.4081/jphia.2022.1923
Published
Abstract Display: 554 
PDF Downloads: 286 
